Phase I and pharmacokinetic study of sorafenib, an oral multikinase inhibitor, in Japanese patients with advanced refractory solid tumors.
Cancer Sci
; 99(7): 1492-8, 2008 Jul.
Article
in En
| MEDLINE
| ID: mdl-18477034
Full text:
1
Database:
MEDLINE
Therapeutic Methods and Therapies TCIM:
Terapias_biologicas
/
Aromoterapia
Main subject:
Pyridines
/
Benzenesulfonates
/
Protein Kinase Inhibitors
/
Neoplasms
/
Antineoplastic Agents
Language:
En
Journal:
Cancer Sci
Year:
2008
Type:
Article
Affiliation country:
Japan